Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 1000
Single User License Price INR 68620
Corporate User License Price USD 3000
Corporate User License Price INR 205860
Site License Price USD 2000
Site License Price INR 137240
Request a Quote

Report Title

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2018 in Pharmaceuticals

Quote Request for License Type
License Type Price  
Single User License USD 1000
Site License USD 2000
Enterprise Wide License USD 3000
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2018 in Pharmaceuticals


Quote Request for License Type
License Type Price  
Single User License USD 1000
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2018 in Pharmaceuticals

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2018 in Pharmaceuticals



Executive Summary

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2018 in Pharmaceuticals

Summary

GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for August 2018 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in August 2018. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData's proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.

- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.

- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.

- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.

- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.

- Analysis of partnership and licensing deals based on clinical stage of development of products.

- Summary of the pharmaceutical deals globally in the six months.

- Information on the top deals happened in the pharmaceutical industry.

- Geographies covered include-North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.

- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.

- Find out the major deal performing segments for investments in your industry.

- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.

- Identify companies that are aggressively looking to raise capital in the market

- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.

- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.

- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.

- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.

- Identify growth segments and opportunities in each region within the industry.

- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 7

2 Pharmaceuticals & Healthcare, Global, Deal Summary 10

2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, August 2018 10

2.2 Pharmaceuticals & Healthcare, Global, Major Deals, August 2018 12

2.2.1 Affimed to Enter into Co-Development Agreement with Genentech 12

2.2.2 Consortium of Investors to Acquire Remaining Shares in China Biologic Products for USD3.9 Billion 12

2.2.3 AstraZeneca Prices Public Offering of Notes USD3 Billion 13

2.2.4 Beijing New Oriental Star Petrochemical Engineering to Acquire Jiangsu Aosaikang Pharmaceutical for USD1.2 Billion 13

2.2.5 Emergent BioSolutions to Acquire Adapt Pharma for up to USD735 Million 13

2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, August 2018 15

2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, August 2018 16

3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 17

3.1 Pharmaceuticals & Healthcare, Global, M&A, August 2018 17

3.1.1 Top M&A Deals in August 2018 18

3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, March 2018-August 2018 18

3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, August 2018 20

3.2.1 Top Equity Offering Deals in August 2018 21

3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, March 2018-August 2018 22

3.2.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, August 2018 23

3.2.4 Top PE/VC Deals in August 2018 24

3.2.5 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, August 2018 25

3.2.6 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, August 2018 26

3.2.7 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, March 2018-August 2018 27

3.2.8 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2018-August 2018 28

3.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, August 2018 29

3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, March 2018-August 2018 30

3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (USD m), August 2018 31

3.5.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, August 2018 32

3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (USD m), March 2018-August 2018 33

3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, March 2018-August 2018 35

3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (USD m), March 2018-August 2018 36

3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (USD m), March 2018-August 2018 37

4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2018 39

4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2018 39

4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (USD m), August 2018 40

4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (USD m), March 2018-August 2018 41

4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (USD m), March 2018-August 2018 42

4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (USD m), March 2018-August 2018 43

4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (USD m), March 2018-August 2018 45

4.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, August 2018 46

4.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, August 2018 47

4.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, August 2018 47

5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 48

5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, August 2018 48

5.1.1 Oncology-Deals of the Month 49

5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, August 2018 51

5.2.1 Central Nervous System-Deals of the Month 52

5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, August 2018 53

5.3.1 Infectious Diseases-Deals of the Month 54

5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, August 2018 55

5.4.1 Cardiovascular-Deal of the Month 56

5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, August 2018 57

5.5.1 Immunology-Deal of the Month 58

5.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, August 2018 59

5.6.1 Gastrointestinal-Deal of the Month 60

5.7 Pharmaceuticals & Healthcare, Global, Dermatology, Deals, August 2018 61

5.7.1 Dermatology-Deal of the Month 62

6 Deal Summary by Geography 63

6.1 Pharmaceuticals & Healthcare, North America Deals, August 2018 63

6.1.1 North America-Deals of the Month 64

6.2 Pharmaceuticals & Healthcare, Europe, Deals, August 2018 66

6.2.1 Europe-Deals of the Month 67

6.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, August 2018 69

6.3.1 Asia-Pacific-Deals of the Month 70

6.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, August 2018 71

6.4.1 Rest of the World-Deals of the Month 72

7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 73

7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, March 2018-August 2018 73

7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, March 2018-August 2018 74

8 Further Information 75

8.1 Methodology 75

8.2 About GlobalData 76

8.3 Contact Us 76

8.4 Disclosure information 76

8.5 Disclaimer 77

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

1.2 List of Figures

Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (USD m), March 2018-August 2018 10

Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), August 2018 15

Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), August 2018 16

Figure 4: Pharmaceuticals & Healthcare, Global, M&As, Number of Deals and Deal Values (USD m), March 2018-August 2018 17

Figure 5: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (USD m), by Therapy Area, March 2018-August 2018 18

Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (USD m), March 2018-August 2018 20

Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (USD m), March 2018-August 2018 22

Figure 8: Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (USD m), March 2018-August 2018 23

Figure 9: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (USD m), by Therapy Area, March 2018-August 2018 25

Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), August 2018 26

Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), August 2018 26

Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (USD m), March 2018-August 2018 27

Figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (USD m), March 2018-August 2018 29

Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (USD m), March 2018-August 2018 30

Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (USD m), March 2018-August 2018 31

Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (USD m), March 2018-August 2018 33

Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2018-August 2018 35

Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2018-August 2018 36

Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (USD m), March 2018-August 2018 37

Figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (USD m), March 2018-August 2018 39

Figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (USD m), March 2018-August 2018 40

Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (USD m), March 2018-August 2018 41

Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (USD m), March 2018-August 2018 42

Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, March 2018-August 2018 43

Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (USD m), March 2018-August 2018 44

Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (USD m), August 2018 45

Figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (USD m), March 2018-August 2018 48

Figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (USD m), March 2018-August 2018 51

Figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (USD m), March 2018-August 2018 53

Figure 30: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (USD m), March 2018-August 2018 55

Figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (USD m), March 2018-August 2018 57

Figure 32: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 59

Figure 33: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 61

Figure 34: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (USD m), March 2018-August 2018 63

Figure 35: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (USD m), March 2018-August 2018 66

Figure 36: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (USD m), March 2018-August 2018 69

Figure 37: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (USD m), March 2018-August 2018 71

Figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (USD m), March 2018-August 2018 73

Figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (USD m), March 2018-August 2018 74

1.1 List of Tables

Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 11

Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, August 2018 12

Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), August 2018 16

Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 17

Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, August 2018 18

Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (USD m), by Therapy Area, March 2018-August 2018 19

Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 21

Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, August 2018 21

Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 22

Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 24

Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, August 2018 24

Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, March 2018-August 2018 25

Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Values (%), August 2018 27

Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (USD m), March 2018-August 2018 28

Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2018-August 2018 28

Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (USD m), March 2018-August 2018 29

Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (USD m), March 2018-August 2018 30

Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (USD m), March 2018-August 2018 31

Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (USD m), August 2018 32

Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (USD m), March 2018-August 2018 34

Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2018-August 2018 36

Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (USD m), March 2018-August 2018 38

Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 39

Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (USD m), March 2018-August 2018 40

Table 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (USD m), March 2018-August 2018 41

Table 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (USD m), August 2018 42

Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2018-August 2018 44

Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (USD m), August 2018 46

Table 29: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, August 2018 46

Table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, August 2018 47

Table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, August 2018 47

Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 49

Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 52

Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 54

Table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 56

Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 58

Table 37: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 60

Table 38: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 62

Table 39: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 64

Table 40: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 67

Table 41: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 70

Table 42: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (USD m), March 2018-August 2018 71

Table 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (USD m), March 2018-August 2018 73

Table 44: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (USD m), March 2018-August 2018 74

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Pharma, Pharmaceuticals, Healthcare, Deal Value, Deal Volume, Private Equity, Venture Capital, Partnership, Licensing, Agreements, North America, Europe, Asia-Pacific, Rest of the World (ROW), Merger, M&A, Acquisition, Equity Offering, Debt Offering, Capital raising, Asset Purchase, Private Placement, Secondary offering, IPO, Initial Public Offer, cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, women's health, Upfront Payment, Milestone Payment, Phases, Clinical Trials


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person